To compare effect of drugs L-carnitine and N-Acetyl-Cysteine in blood transfusion dependent thalassemia patients
Phase 3
- Conditions
- Health Condition 1: D561- Beta thalassemia
- Registration Number
- CTRI/2024/06/068935
- Lead Sponsor
- Dr Pragna Roy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients with thalassemia on blood transfusion
2)Patients or legally authorized representative willing to give informed consent and assent for the trial.
Exclusion Criteria
1)Patients with history of allergic reactions attributed to compounds of similar chemical or biologic composition of N-Acetyl-Cysteine and L-Carnitine
2)Patients with history of central nervous system diseases (like epilepsy, psychiatric disorder) or taking any medicine for such illness.
3)Patients with history of severe renal or hepatic disease (like hepatitis B or C)
4)Patients with history of bronchospastic diseases (like asthma)
5)Patients with history of hypothyroid disorder
6)Patients on warfarin or acenocoumarin therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method